June 14, 2022
Triptan use during pregnancy does not increase the risk for attention- deficit/hyperactivity disorder (ADHD) in offspring, new research suggests. Hedvig Nordeng, PhD “The findings should reassure […]
June 14, 2022
The US Food and Drug Administration (FDA) has cleared the first exoskeleton device for use in the rehabilitation of patients with multiple sclerosis (MS). The FDA […]
June 13, 2022
NATIONAL HARBOR, MD – How often do patients with multiple sclerosis (MS) end up taking drugs that could dangerously interact with other medications they’re taking? A […]
June 13, 2022
CHARLOTTE, N.C. – Overnight sleep electroencephalography (EEG) contains an abundance of brain wave data that could be mined to identify an individual’s risk for a host […]
June 10, 2022
Two rare mutations in the APOE gene ― APOE ε4 (R251G) and APOE ε3 (V236E) ― dramatically reduce the risk of developing Alzheimer’s disease (AD), results […]
June 10, 2022
Herpes zoster does not appear to increase dementia risk ― on the contrary, the viral infection may offer some protection, a large population-based study suggests. “We […]
June 10, 2022
The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Mild traumatic brain injury […]
June 10, 2022
Physicians and patients agree on the importance of sleep for health, yet few clinicians obtain a patient sleep history, and few patients discuss their sleep problems […]
June 10, 2022
NATIONAL HARBOR, Maryland — Ublituximab (TG Therapeutics, Inc), an investigational anti-CD20 monoclonal antibody infused once every 6 months, is effective for treating relapsing forms of multiple […]